Lipid mediator networks and leukocyte transmigration.
In intact tissues, vascular endothelial cells lie anatomically positioned as the central coordinator of inflammation. Endothelia communicate with underlying cells (e.g. smooth muscle, fibroblasts, epithelia) in ways that both coordinate leukocyte trafficking, and control the composition of the inflammatory microenvironment. Such coordination occurs through both direct communication (e.g. cell adhesion) as well as via soluble mediators liberated at sites of inflammation (e.g. chemokines, cytokines, lipids). Locally generated mediators bind to surface receptors, and mediate both physiologic and pathophysiologic functional responses. Important in this regard, both endothelial and subendothelial cell populations express enzymes capable of utilizing arachidonic acid substrates to generate bioactive lipid mediators (e.g. lipoxygenases, cyclooxygenases). Such lipid mediators can signal via autocrine or paracrine pathways and, depending on the tissue microenvironment, can convey a pro- or anti-inflammatory message. This review will highlight recent studies characterizing inflammatory responses to lipid mediators liberated at sites of inflammation, with a particular emphasis on neutrophil (polymorphonuclear leukocyte or PMN) trafficking.
Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Nancy A
NA
Louis
Kathryn E
KE
Hamilton
Sean P
SP
Colgan
D051546:Cyclooxygenase 2 / Q000378:metabolism; D000860:Hypoxia / Q000503:physiopathology; D007249:Inflammation / Q000276:immunology*; D044045:Lipoxins / Q000276:immunology*; D018375:Neutrophil Activation; D009504:Neutrophils / Q000502:physiology*; D010972:Platelet Activating Factor; D044067:Receptors, Lipoxin
D044045:Lipoxins; D010972:Platelet Activating Factor; D044067:Receptors, Lipoxin; D051546:Cyclooxygenase 2